| Application number | Title of the application | Filing Date | Status |
|---|
Array
(
[id] => 6921762
[patent_doc_number] => 20010029247
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2001-10-11
[patent_title] => 'USE OF A- ALKYLGLUCOSIDES AND A-ALKYLGLUCOSIDE ESTERS AS ANTI-MICROBIAL EMULSIFYING AGENTS'
[patent_app_type] => new
[patent_app_number] => 09/197798
[patent_app_country] => US
[patent_app_date] => 1998-11-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 3091
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 10
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0029/20010029247.pdf
[firstpage_image] =>[orig_patent_app_number] => 09197798
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/197798 | Use of -alkylglucosides and -alkylglucoside esters as anti-microbial an agents | Nov 22, 1998 | Issued |
| 09/196206 | METHOD OF INHIBITING NEOPLASTIC CELLS WITH IMIDAZOQUINAZOLINE DERIVATIVES | Nov 19, 1998 | Abandoned |
| 09/192493 | PHARMACEUTICAL COMPOSITIONS BASED ON DICLOFENAC | Nov 16, 1998 | Abandoned |
Array
(
[id] => 4028163
[patent_doc_number] => 05902801
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 1999-05-11
[patent_title] => 'Glucosamine sulfate metal chloride compositions and process of preparing same'
[patent_app_type] => 1
[patent_app_number] => 9/191169
[patent_app_country] => US
[patent_app_date] => 1998-11-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3513
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/05/902/05902801.pdf
[firstpage_image] =>[orig_patent_app_number] => 191169
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191169 | Glucosamine sulfate metal chloride compositions and process of preparing same | Nov 12, 1998 | Issued |
Array
(
[id] => 4358878
[patent_doc_number] => 06174886
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-01-16
[patent_title] => 'Antipsychotic use of triazolo-pyridazine derivatives'
[patent_app_type] => 1
[patent_app_number] => 9/191304
[patent_app_country] => US
[patent_app_date] => 1998-11-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11136
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/174/06174886.pdf
[firstpage_image] =>[orig_patent_app_number] => 191304
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/191304 | Antipsychotic use of triazolo-pyridazine derivatives | Nov 11, 1998 | Issued |
Array
(
[id] => 4411969
[patent_doc_number] => 06265570
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-07-24
[patent_title] => 'Cold water soluble starch aldehydes and the method of preparation thereof'
[patent_app_type] => 1
[patent_app_number] => 9/186503
[patent_app_country] => US
[patent_app_date] => 1998-11-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4287
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 173
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/265/06265570.pdf
[firstpage_image] =>[orig_patent_app_number] => 186503
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/186503 | Cold water soluble starch aldehydes and the method of preparation thereof | Nov 4, 1998 | Issued |
Array
(
[id] => 1447006
[patent_doc_number] => 06369109
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-04-09
[patent_title] => 'Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor'
[patent_app_type] => B1
[patent_app_number] => 09/182588
[patent_app_country] => US
[patent_app_date] => 1998-10-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 38
[patent_figures_cnt] => 48
[patent_no_of_words] => 31324
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 30
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/369/06369109.pdf
[firstpage_image] =>[orig_patent_app_number] => 09182588
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/182588 | Betulinic acid and derivatives thereof useful for the treatment of neuroectodermal tumor | Oct 27, 1998 | Issued |
| 09/147095 | PROCESS FOR THE PREPARATION OF IVERMECTIN | Oct 26, 1998 | Abandoned |
Array
(
[id] => 4188046
[patent_doc_number] => 06160128
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-12-12
[patent_title] => 'Tritioacetylating reagents and processes for preparation thereof'
[patent_app_type] => 1
[patent_app_number] => 9/177882
[patent_app_country] => US
[patent_app_date] => 1998-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 9
[patent_no_of_words] => 10564
[patent_no_of_claims] => 34
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 45
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/160/06160128.pdf
[firstpage_image] =>[orig_patent_app_number] => 177882
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/177882 | Tritioacetylating reagents and processes for preparation thereof | Oct 22, 1998 | Issued |
Array
(
[id] => 4327572
[patent_doc_number] => 06329422
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2001-12-11
[patent_title] => 'Compositions and methods for cystic fibrosis therapy'
[patent_app_type] => 1
[patent_app_number] => 9/174077
[patent_app_country] => US
[patent_app_date] => 1998-10-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 19
[patent_figures_cnt] => 24
[patent_no_of_words] => 16175
[patent_no_of_claims] => 32
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 26
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/329/06329422.pdf
[firstpage_image] =>[orig_patent_app_number] => 174077
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/174077 | Compositions and methods for cystic fibrosis therapy | Oct 15, 1998 | Issued |
| 09/172685 | CALPAIN INHIBITORS AND THEIR APPLICATIONS | Oct 14, 1998 | Abandoned |
| 09/169678 | METHOD OF INHIBITING NEOPLASTIC CELLS WITH TETRACYCLIC PYRIOD(3,4-B)INDOLE DERIVATIVES | Oct 8, 1998 | Abandoned |
Array
(
[id] => 1507796
[patent_doc_number] => 06440947
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-08-27
[patent_title] => 'Method for treating occlusive peripheral vascular disease and coronary disease'
[patent_app_type] => B1
[patent_app_number] => 09/167816
[patent_app_country] => US
[patent_app_date] => 1998-10-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10081
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 50
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/440/06440947.pdf
[firstpage_image] =>[orig_patent_app_number] => 09167816
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/167816 | Method for treating occlusive peripheral vascular disease and coronary disease | Oct 6, 1998 | Issued |
| 09/167634 | COMPOSITIONS AND METHODS OF INHIBITING NEOPLASTIC DISEASES WITH COMPOUNDS RELATED TO LIMOCITRIN AND 5-DESMETHYL SINENSETIN | Oct 5, 1998 | Abandoned |
Array
(
[id] => 7631179
[patent_doc_number] => 06635753
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2003-10-21
[patent_title] => 'Process for the preparation of substantially pure stavudine and related intermediates useful in the preparation thereof'
[patent_app_type] => B1
[patent_app_number] => 09/163321
[patent_app_country] => US
[patent_app_date] => 1998-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3478
[patent_no_of_claims] => 31
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 13
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/635/06635753.pdf
[firstpage_image] =>[orig_patent_app_number] => 09163321
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/163321 | Process for the preparation of substantially pure stavudine and related intermediates useful in the preparation thereof | Sep 29, 1998 | Issued |
Array
(
[id] => 1528745
[patent_doc_number] => 06479657
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-11-12
[patent_title] => 'Crystalline 1-kestose and process for preparing the same'
[patent_app_type] => B1
[patent_app_number] => 09/091182
[patent_app_country] => US
[patent_app_date] => 1998-09-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13322
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 28
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/479/06479657.pdf
[firstpage_image] =>[orig_patent_app_number] => 09091182
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/091182 | Crystalline 1-kestose and process for preparing the same | Sep 28, 1998 | Issued |
| 09/117115 | CONCENTRATED INJECTION AND INFUSION SOLUTIONS FOR INTRAVENOUS ADMINISTRATION | Sep 21, 1998 | Abandoned |
Array
(
[id] => 4184005
[patent_doc_number] => 06150337
[patent_country] => US
[patent_kind] => NA
[patent_issue_date] => 2000-11-21
[patent_title] => 'Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes'
[patent_app_type] => 1
[patent_app_number] => 9/156646
[patent_app_country] => US
[patent_app_date] => 1998-09-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 4835
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/150/06150337.pdf
[firstpage_image] =>[orig_patent_app_number] => 156646
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/156646 | Specific modulation of Th1/Th2 cytokine expression by Ribavirin in activated T-lymphocytes | Sep 17, 1998 | Issued |
Array
(
[id] => 1575772
[patent_doc_number] => 06469161
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-10-22
[patent_title] => 'Chemical fluidification process and conversion process of starchy materials, and new cationic starchy materials'
[patent_app_type] => B1
[patent_app_number] => 09/150680
[patent_app_country] => US
[patent_app_date] => 1998-09-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6660
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 43
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/469/06469161.pdf
[firstpage_image] =>[orig_patent_app_number] => 09150680
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/150680 | Chemical fluidification process and conversion process of starchy materials, and new cationic starchy materials | Sep 9, 1998 | Issued |
Array
(
[id] => 1565342
[patent_doc_number] => 06339073
[patent_country] => US
[patent_kind] => B1
[patent_issue_date] => 2002-01-15
[patent_title] => 'Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases'
[patent_app_type] => B1
[patent_app_number] => 09/149998
[patent_app_country] => US
[patent_app_date] => 1998-09-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 8
[patent_figures_cnt] => 8
[patent_no_of_words] => 4311
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 70
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/06/339/06339073.pdf
[firstpage_image] =>[orig_patent_app_number] => 09149998
[rel_patent_id] =>[rel_patent_doc_number] =>) 09/149998 | Uses of nicotinamide adenine dinucleotide and its derivatives for treatment of malignant and infectious diseases | Sep 8, 1998 | Issued |